EMA Authorised: Cholib (fenofibrate;simvastatin) — Viatris Healthcare Limited

View source ↗

Summary

Cholib, a fixed-dose combination of fenofibrate and simvastatin, has been authorised for dyslipidemias in the European Union.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias

Drugs mentioned

• Cholib (fenofibrate; simvastatin)

Snippet

Status: Authorised. Therapeutic area: Dyslipidemias. MAH: Viatris Healthcare Limited. Decision date: 28/06/2026